Cytosorbents (CTSO) Tops Q3 EPS by 1c, Misses on Revenue

Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $10.4 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Nasdaq grants Snail Games conditional listing extension for SNAL stock
• MiniMed Group (MMED) Reiterated at Buy by StoneX Ahead of Q1 Earnings